Australia, NZ dollars hit pause as rate outlook pondered
Minutes of the Reserve Bank of Australia July board meeting confirmed further cuts lay ahead and a decision to pause at 3.85% was largely because the majority did not want to be seen as easing too quickly.
One of the arguments against an immediate cut was that the labour market had not loosened as forecast, but data since then has shown unemployment unexpectedly spiked to a 3-1/2 year high in June.
As a result, markets imply almost a 100% chance the RBA will ease to 3.60% at its next meeting on August 12, and take rates to 3.10% by the end of the year.
"We expect another three 25 bps rate cuts this cycle - in August, November and February - down to a 3.1% terminal rate," said Andrew Boak, an economist at Goldman Sachs.
"We view the risks as skewed to a faster and deeper easing cycle, and particularly if June's gap higher in the unemployment rate is sustained."
A speech by RBA Governor Michele Bullock due on Thursday should help refine the outlook and she is likely to draw questions on whether the central bank is being too slow to ease given the disappointing labour data.
Three-year bond futures were supported near a two-week high of 96.635, while 10-year yields dipped 2 basis points to 4.308%.
The Aussie held steady at $0.6520, some way above last week's low of $0.6455. Resistance lies around $0.6540 and $0.6595.
The kiwi dollar eased a fraction to $0.5960, still weighed by a downside surprise on quarterly inflation. Major support lies at $0.5907 with resistance at $0.5990.
Markets now imply around an 80% probability the Reserve Bank of New Zealand will cut the 3.25% cash rate a quarter point at its meeting on August 20.
Investors suspect this will be close to the end of the easing cycle, with some chance of a move to 2.75% next year.
The RBNZ's chief economist is due to give a speech on the economic impact of tariffs on Thursday and might help refine the prospects of an August easing. (Reporting by Wayne Cole; Editing by Kate Mayberry)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
25 minutes ago
- Economic Times
Biocon Biologics launches product for autoimmune diseases in Australia
Biocon on Wednesday said its subsidiary Biocon Biologics has launched a product for the treatment of autoimmune diseases like rheumatoid arthritis, in the Australian market. The company has launched Nepexto, a biosimilar to the reference product Enbrel (Etanercept), in Australia, the company said in a regulatory filing. Nepexto will be promoted by Generic Health, a local partner and a leading provider of high-quality generic prescription, injectable and over-the-counter medicines, to expand access to patients in that country, it added. Etanercept is a fusion-protein that inhibits tumour necrosis factor (TNF) and is used in the treatment of autoimmune diseases like rheumatoid arthritis, juvenile idiopathic arthritis and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. Since receiving EU marketing authorisation in 2020, Nepexto has earned broad adoption across Europe. Following the 2022 acquisition and vertical integration of the biosimilars business globally, Biocon Biologics is building on the solid foundation to strategically expand Nepexto into new markets worldwide and further strengthen its immunology offering, it said. Shares of Biocon were trading 1.72 per cent up at Rs 393.70 apiece on BSE.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
India to resume tourist visas to Chinese nationals from July 24 after 5 yrs
India will start issuing tourist visas to Chinese nationals from July 24 after halting them for five years, Reuters reported, citing the Indian Embassy in China. The development marks a shift in the strained ties between the two countries, which are aiming to improve ties and ease tensions after Galwan clashes in 2020. Chinese media Global Times shared the post made by the Indian Embassy in China on Weibo. Sharing the post on X, it said, "The Embassy of India in China announced via its Sina Weibo account on Wednesday that, starting from July 24, 2025, Chinese citizens can apply for a tourist visa to visit India after completing an online application, scheduling an appointment, and personally submitting their passport and other required documents to the Indian Visa Application Centers in Beijing, Shanghai, and Guangzhou, in South China's Guangdong Province." It further added, "This marks the first time since the suspension in 2020 that India has resumed issuing tourist visas to Chinese citizens after a five-year hiatus, according to media reports." India suspends visas for Chinese nationals In 2020, India suspended all tourist visas for Chinese nationals in light of the Covid-19 pandemic. In April 2022, the International Air Transport Association (IATA) issued a notice, stating that all tourist visas to Chinese nationals will no longer be valid. The move came in retaliation after China limited the re-entry of as many as 22,000 Indian students in the country after the Covid-19 pandemic. Breakthrough in India-China ties Earlier in March this year, Chinese Foreign Minister Wang Yi highlighted positive developments in India-China relations. He added that both countries have made positive strides in their bilateral ties and achieved encouraging outcomes. Yi emphasised the need for a cooperative partnership between the dragon (China) and the elephant (India). He stated, "China believes that as the largest neighbors, both countries should be partners in each other's success." He attributed the positive developments between the two countries to a successful meeting held between Prime Minister Narendra Modi and Chinese President Xi Jinping at Kazan, Russia.
Mint
2 hours ago
- Mint
Rise in overnight swap rate, lower US bond yields boost forward premiums
MUMBAI, July 23 (Reuters) - India's dollar-rupee forward premiums rose across tenors, due to the combined impact of a rise in the cost of borrowing the rupee overnight and a dip in near-term U.S. Treasury yields, while the local currency was flat in the spot market. The dollar-rupee overnight swap rate rose to 0.38 paisa on Wednesday, lifting near-tenor forward premiums to a one-month high and supporting long-term tenors as well, aided by a dip in the one-year U.S. Treasury yield. The one-month forward premium advanced to 12.50 paisa, while the 1-year implied yield rose by 2 basis points to a three-week high of 2.05%. The 1-year U.S. Treasury yield was last at 4.08% after hitting a two-week low overnight. Tighter rupee liquidity in the banking system pushed up the overnight swap rate, according to traders. India's banking system liquidity is currently hovering near a seven-week low but it is expected to improve in next few days, which may help cool off near-tenor forward premiums. On the far end, "there is limited appetite to run a paid position," a trader at a large private bank said, citing rising chances of the Federal Reserve holding interest rates steady for longer and growing expectations of a rate cut by the Reserve Bank of India in its August policy meeting. Meanwhile, in the spot market, the rupee was nearly flat at 86.37 per U.S. dollar as of 12:15 p.m., wedged between positive cues from gains in most regional peers and routine dollar demand from local importers. The dollar index was steady at 97.5, while the Chinese yuan strengthened to a three-week high, buoyed by fresh signs of easing trade tensions and a persistently stronger-than-expected guidance fix by the country's central bank. U.S. and Chinese officials are slated to discuss an extension to the tariff deadline of August 1 for negotiating a trade deal. (Reporting by Jaspreet Kalra; Editing by Rashmi Aich)
